Companies / BOC Sciences / Omburtamab
BOC Sciences

Omburtamab | BOC Sciences

Omburtamab is a radiolabeled monoclonal antibody 8H9 (131I-8H9) developed to target B7-H3-expressing cells in solid tumors.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.